Press release
Generic Drugs Market Trends 2024 | Segmentation, Outlook, Industry Report to 2031
Generic Drugs Market
Get Free Sample link @ https://www.omrglobal.com/request-sample/generic-drugs-market
Further, in 2019, the Chinese authorities declared the launch of an initiative to encourage the development of generic medicines. In June 2019, China's National Health Commission revealed its first list of 34 drugs with no generic drug counterpart, near to patent expiration, and are off-patent. Under the drug regulator's priority review pathway, drug manufacturers are being pushed to develop generic medicines. The list covers Teva's Copaxone, a multiple sclerosis drug, and Roche's Valcyte, a Cytomegalovirus (CMV) retinitis treatment. Big pharmaceutical firms are being competed with manufacturers of generic drugs in China. These kinds of initiatives are accelerating the launches of generic drugs at much lower prices, which is supporting to drive market growth.
Full report of Generic Drugs Market available @ https://www.omrglobal.com/industry-reports/generic-drugs-market
Scope of the Global Generic Drugs Market
Market Coverage
Segment Covered- By Application and Route of Administration
Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
Competitive Landscape- Mylan N.V., Teva Pharmaceutical Industries Ltd., Lupin Ltd., Novartis International AG, and Sun Pharmaceutical Industries Ltd.
Recent Strategic Initiatives in the Global Generic Drugs Market
In October 2020, Teva Pharmaceuticals USA, Inc. declared the availability of the first US FDA-approved generic versions of TRUVADA i and ATRIPLA i tablets. These products, along with over 10 HIV-related drugs are already on the WHO's Essential Medicines List. By launching these new generic options for HIV treatment, Teva will further increase access to vital therapies and strengthen its position in the generic marketplace.
In September 2020, Sun Pharmaceutical Industries Ltd. declared the launch of ILUMYA (tildrakizumab) Subcutaneous Injection 100 mg Syringe in Japan to treat adult patients suffering from plaque psoriasis who have an insufficient response to traditional therapies. ILUMYA is a humanized lgG1/k monoclonal antibody that is intended to selectively attach to the p19 subunit of IL23 and stops its interaction with the IL-23 receptor. This leads to an inhibition of the release of chemokines and proinflammatory cytokines.
Key questions addressed by the report
What is the market growth rate?
Which segment/region dominates the market in the base year?
Which segment/region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Generic Drugs Market-Segmentation
By Application
Cancer
CVD
Musculoskeletal Diseases
Infectious Diseases
Neurology
Diabetes
Others
By Route of Administration
Oral
Topical
Injectable
Inhaler
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/generic-drugs-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Drugs Market Trends 2024 | Segmentation, Outlook, Industry Report to 2031 here
News-ID: 3605961 • Views: …
More Releases from Orion Market Reseach
Dual Carbon Battery Market Set to Witness Significant Growth by 2033 | Toshiba C …
The Dual Carbon Battery Market was valued at USD 192.8 million in 2024 and is projected to reach approximately USD 503.5 million by 2033, growing at a CAGR of 11.4% from 2025 to 2033.
Dual Carbon Battery Market Overview
The Dual Carbon Battery Market is witnessing growing traction due to its sustainable and high-performance energy storage capabilities. Unlike traditional batteries, dual carbon batteries utilize both the anode and cathode made from carbon,…
Building-Integrated Photovoltaics (BIPV) Market By Application Analysis, Regiona …
The global Building-Integrated Photovoltaics (BIPV) market was valued at approximately USD 19.8 billion in 2024, and it is expected to reach around USD 89.7 billion by 2033, growing at a compound annual growth rate (CAGR) of 18.3% from 2025 to 2033.
Building-Integrated Photovoltaics (BIPV) Market Overview:
The Building-Integrated Photovoltaics (BIPV) market is rapidly expanding as demand for sustainable and energy-efficient construction solutions rises worldwide. BIPV systems, which integrate solar panels directly into…
Active Protection System Market Size Trends and Forecast by Application, Type, a …
The global active protection system market was valued at approximately USD 4.25 billion in 2023 and is projected to reach around USD 8.76 billion by 2034, indicating a compound annual growth rate (CAGR) of approximately 6.5% from 2024 to 2032.
Active Protection System Market Overview
The active protection system market is experiencing significant growth, driven by increasing global defense spending and the rising need for advanced military technologies to counter…
Plant-based Snacks Market Future Prediction Report By 2032
The global plant-based snacks market was valued at approximately USD 45.9 billion in 2023 and is projected to reach USD 77.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.85% from 2024 to 2032.
Plant-based Snacks Market Overview
The plant-based snacks market has experienced significant growth in recent years, driven by increasing consumer awareness of health, sustainability, and ethical considerations. Consumers are increasingly seeking healthier snack alternatives…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
